Search research articles
Contact Us
Filters
Showing results (71-80 of 164) with videos related to
Page
of 17
Sort By:
Leukemia & Lymphoma
|
August 17, 2022
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
Aspasia Stamatoullas, Hervé Ghesquières, Pierre Feugier, et al.
Blood Advances
|
October 7, 2025
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnostic
Aurélie Montagne, Gildas Bertho, Thomas Papastergiou, et al.
British Journal of Haematology
|
April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)
Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
British Journal of Haematology
|
September 15, 2025
Anti-CD19 CAR T-cell therapy for patients with Richter transformation: A LYSA study from the DESCAR-T registry
Hedi Bensaber, Emmanuel Ferrant, Rémy Duléry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2009
Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study
Christiane Copie-Bergman, Philippe Gaulard, Karen Leroy, et al.
Haematologica
|
June 9, 2022
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
Jean Galtier, Laetitia Vercellino, Loic Chartier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2016
Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
Clémentine Sarkozy, Marek Trneny, Luc Xerri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
Jehan Dupuis, Alina Berriolo-Riedinger, Anne Julian, et al.
Haematologica
|
May 7, 2011
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA
Olivier Fitoussi, Karim Belhadj, Nicolas Mounier, et al.
Journal of Crohn'S & Colitis
|
October 18, 2023
Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA
Marie Muller, Julien Broséus, Adrien Guilloteau, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 164) with videos related to
Sort By:
Page
of 17
Leukemia & Lymphoma
|
August 17, 2022
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study
Aspasia Stamatoullas, Hervé Ghesquières, Pierre Feugier, et al.
Blood Advances
|
October 7, 2025
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnostic
Aurélie Montagne, Gildas Bertho, Thomas Papastergiou, et al.
British Journal of Haematology
|
April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)
Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
British Journal of Haematology
|
September 15, 2025
Anti-CD19 CAR T-cell therapy for patients with Richter transformation: A LYSA study from the DESCAR-T registry
Hedi Bensaber, Emmanuel Ferrant, Rémy Duléry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2009
Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study
Christiane Copie-Bergman, Philippe Gaulard, Karen Leroy, et al.
Haematologica
|
June 9, 2022
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
Jean Galtier, Laetitia Vercellino, Loic Chartier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2016
Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
Clémentine Sarkozy, Marek Trneny, Luc Xerri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS
Jehan Dupuis, Alina Berriolo-Riedinger, Anne Julian, et al.
Haematologica
|
May 7, 2011
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA
Olivier Fitoussi, Karim Belhadj, Nicolas Mounier, et al.
Journal of Crohn'S & Colitis
|
October 18, 2023
Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA
Marie Muller, Julien Broséus, Adrien Guilloteau, et al.
Page
of 17